Nav: Home

Cancer-associated mutations are common in normal human esophagus

October 18, 2018

Unexpectedly, a new study finds that cancer-associated genetic mutations are surprisingly common in aged, healthy esophageal epithelium tissue. The results further our understanding of cancer and aging and underscore how little is known about the mutational evolution within normal tissues, a process likely ubiquitous in the tissues of all living things. As people get older, they accumulate mutations in the healthy cells of normal tissues. Generally, these mutations accumulate passively and do not alter cell behavior. However, if a genetic alteration provides a mutant cell with a competitive edge, these cells become persistent mutant clones, which are thought to be the origin of cancer. Human skin, exposed to the powerful mutagenic power of the sun's light, is the most highly mutated normal tissue - nearly 25% of cells in the sun-exposed skin of middle-aged individuals carry cancer driver mutations. Despite its importance, the extent to which cells accumulate somatic mutations throughout life is poorly understood, particularly in tissues not exposed to mutagens like ultraviolet light. To explore the mutational burden of other tissues, Iñigo Martincorena and colleagues performed targeted gene sequencing of normal esophageal epithelium - a tissue-like skin, which lines the esophagus - from nine human donors ranging from 20 to 75 years of age. While the mutation rate was lower in the esophageal tissue than in skin, Martincorena et al. revealed a strong positive selection of cellular clones carrying mutations in 14 cancer-associated genes. According to the results, by middle age, over half of the esophageal epithelium tissue contained mutant clones. What's more, Martincorena et al. observed a high frequency of mutations in the cancer driver gene NOTCH1 in aged normal esophageal epithelium. These mutations were more common in normal cells than in esophageal cancer cells, suggesting that esophageal cancers are more likely to evolve from cells in epithelium without NOTCH1 mutations.

American Association for the Advancement of Science

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.